Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$83.3 million.

  • Abivax's Cash from Operations fell 11445.55% to -$83.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$191.9 million, marking a year-over-year change of. This contributed to the annual value of -$164.6 million for FY2024, which is 5670.03% down from last year.
  • As of Q3 2025, Abivax's Cash from Operations stood at -$83.3 million, which was down 11445.55% from -$37.7 million recorded in Q2 2025.
  • Over the past 5 years, Abivax's Cash from Operations peaked at -$35.0 million during Q1 2025, and registered a low of -$83.3 million during Q3 2025.